NEW YORK ( TheStreet) -- Quidel Corporation (Nasdaq: QDEL) hit a new 52-week high Thursday as it is currently trading at $14.81, above its previous 52-week high of $14.80 with 6,387 shares traded as of 9:37 a.m. ET. Average volume has been 228,000 shares over the past 30 days.

Quidel has a market cap of $470 million and is part of the health care sector and drugs industry. Shares are up 1.9% year to date as of the close of trading on Wednesday.

Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of diagnostic testing solutions for applications primarily in infectious diseases, and reproductive and women's health. The company has a P/E ratio of 283.4, below the average drugs industry P/E ratio of 354.3 and above the S&P 500 P/E ratio of 17.7.
  • Practice your QDEL trading strategies and win cash in our stock game.

TheStreet Ratings rates Quidel as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Quidel Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Action Was Under the Surface in Monday's Market

Insider Trading Alert - QDEL, SPRT And SJW Traded By Insiders